Abstract:Abstract Dysregulation of an oncogene by translocation to Ig locus is a common event in the pathogenesis of most non-Hodgkin's lymphoma. Using inverse-PCR, CD44 on 11p13 was identified as a novel translocation partner of IgH in 9 of 114 cases of gastric, non-gastric extranodal, follicular and nodal diffuse large B-cell lymphomas (DLBCLs) analyzed. IgHSμ/CD44 translocation juxtaposes the enhancer of IgHSμ to the 5’ regulatory region of CD44 in a tail-to-head orientation, leading to the removal of exon 1 of CD44. Sequencing analysis showed microhomology sequences at the junction breakpoints of all the IGHSμ/CD44 translocations, suggesting that these translocations were the results of illegitimate switch recombination facilitated by homologous sequences present on both chromosomes. By interphase-FISH using home-grown CD44 dual-color break-apart probes (consisting of BACs RP4-607I7 and RP4-683L5), breakage at the CD44 locus in each of the nine IGHSμ/CD44 translocation-positive cases was confirmed. By 5’ RACE analysis, fusion Iμ-CD44ΔEx1 hybrid transcripts (with a splicing of the Iμ exon upstream of Sμ to exon 2 of CD44), were identified in all the nine lymphomas with IGHSμ/CD44 translocations. Notably, these translocations were detected exclusively in GCB-type DLBCLs. However, CD44 mRNA was minimally or not expressed in CD10+ microdissected reactive GCB cells. The IGHSμ/CD44 translocation substitute Sμ for the CD44 promoter and remove exon 1 of CD44, resulting in over-expression of the Iμ-CD44 hybrid transcript which encodes for a new CD44 variant lacking leader peptide sequence but retaining a unique C-terminus (CD44ΔEx1). The Iμ-CD44ΔEx1 ORF would encode for the CD44ΔEx1 protein starting from the ATG at nucleotide 254 with strong Kozak sequence. The new CD44ΔEx1 variant showed some similarity to CD44v5, but it lacked the leader peptide. The IGHSμ/CD44 translocation was detected in patients with advanced-stage disease (stages III and IV). When overexpressed in vitro in the CD44-negative GCB-DLBCL cell line BJAB, the CD44ΔEx1-GFP was localized to the cytoplasm and nucleus, while CD44s-GFP (standard form) was localized to the plasma membrane. The ectopic expression of CD44ΔEx1 in BJAB cells enhanced the cell proliferation rate and its clonogenic ability. These findings indicate a possible pathogenic role of the recurrent translocation in several malignant B-cell lymphomas. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 258.

[Preliminary Analysis of Mutations in Exon 5 of IkappaBalpha Gene in Hodgkin Lymphoma].

Mutation of IκBα gene in Hodgkins lymphoma:a prelimimary analysis

The Aberrant of IκBα Expression in Hodgkin's Reed-sternberg

Mutations of NFKBIA in Biopsy Specimens from Hodgkin Lymphoma

[Study of Mutations in 5'-Noncoding Region of BCL-6 Gene in B-cell Non-Hodgkin's Lymphomas].

Analysis of Hypermutation of the 5' Noncoding Region in the Bcl-6 Gene

Clinical and Genetic Characteristics of <i>IKZF1</i> Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia

Clinical Significance of MYD88 non‐L265P Mutations in Diffuse Large B‐Cell Lymphoma

Clonality Analysis and Mutational Status of IgVH Gene in Hodgkin Variant of Richter Syndrome

[A Genetic Analysis of Children with Epstein-Barr Virus-Positive Hemophagocytic Lymphohistiocytosis and Its Association with T-helper Type 1/T-Helper Type 2 Cytokines].

A Novel CD40LG Mutation Causing X‑linked Hyper-Igm Syndrome

Abstract 4974: IL-1 Receptor-Associated Kinase-1 and -4 Expression in Hodgkin Lymphoma

Abstract 258: Molecular Features and Functional Consequence of CD44 Activation by a Novel Recurrent IGH Translocation T(11;14) (p13;q32) in Mature B-cell Lymphoid Neoplasm

[Acquired Somatic Mutations in Non-Coding Region of Bcl-6 Gene in Germinal Center-Type Diffuse Large B-cell Lymphoma].

[Analysis of mutations in IgVH genes in diffuse large B-cell lymphomas].

MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis

[Mutation of 5'noncoding Region of the Bcl-6 Gene in Diffuse Large B Cell Lymphomas].

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

Analysis of CCM1 Gene 8 ~(th) Exon Mutation of Intracranial Cavernous Angiomas and A New 704inst Insertion Site

Point Mutation of 5 ' Noncoding Region of Bcl-6 Gene in Primary Gastric Lymphomas

Mutational Analysis of the Transforming Growth Factor Β Receptor Type I Gene in Primary Non-Small Cell Lung Cancer